4D Molecular Therapeutics, Inc. Other Nonoperating Income (Expense)
4D Molecular Therapeutics, Inc. (FDMT) reported Other Nonoperating Income (Expense) of -$166.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-13
- 4D Molecular Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$166.00K.
- 4D Molecular Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$4.00K, a 105.97% decline year-over-year.
- 4D Molecular Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$22.00K.
- 4D Molecular Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$21.00K.
- 4D Molecular Therapeutics, Inc. other nonoperating income (expense) for fiscal 2025 was -$37.00K.
- 4D Molecular Therapeutics, Inc. other nonoperating income (expense) for fiscal 2024 was -$77.00K.
- 4D Molecular Therapeutics, Inc. other nonoperating income (expense) for fiscal 2023 was -$181.00K.
- 4D Molecular Therapeutics, Inc. other nonoperating income (expense) for fiscal 2022 was -$35.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$166.00K 10-Q · filed 2026-08-13 | -$169.00K 10-Q · filed 2026-08-13 | -$192.00K derived: sum of 3 quarters · filed 2026-08-13 | -$213.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$4.00K 10-Q · filed 2026-05-07 | -$26.00K derived: sum of 2 quarters · filed 2026-05-07 | -$47.00K derived: sum of 3 quarters · filed 2026-05-07 | -$108.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$43.00K derived: sum of 2 quarters · filed 2026-03-18 | -$104.00K derived: sum of 3 quarters · filed 2026-08-13 | -$37.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | -$21.00K 10-Q · filed 2025-11-10 | -$82.00K derived: sum of 2 quarters · filed 2026-08-13 | -$15.00K 10-Q · filed 2025-11-10 | -$36.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$61.00K 10-Q · filed 2026-08-13 | $6.00K 10-Q · filed 2026-08-13 | -$15.00K derived: sum of 3 quarters · filed 2026-08-13 | -$16.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $67.00K 10-Q · filed 2026-05-07 | $46.00K derived: sum of 2 quarters · filed 2026-05-07 | $45.00K derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$22.00K derived: sum of 2 quarters · filed 2026-03-18 | -$67.00K derived: sum of 3 quarters · filed 2026-03-18 | -$77.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | -$1.00K 10-Q · filed 2025-11-10 | -$46.00K derived: sum of 2 quarters · filed 2025-11-10 | -$56.00K 10-Q · filed 2025-11-10 | -$67.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$45.00K 10-Q · filed 2025-08-11 | -$55.00K 10-Q · filed 2025-08-11 | -$66.00K derived: sum of 3 quarters · filed 2025-08-11 | -$224.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$10.00K 10-Q · filed 2025-05-08 | -$21.00K derived: sum of 2 quarters · filed 2025-05-08 | -$179.00K derived: sum of 3 quarters · filed 2025-05-08 | -$171.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$169.00K derived: sum of 2 quarters · filed 2025-02-28 | -$161.00K derived: sum of 3 quarters · filed 2025-02-28 | -$181.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | -$158.00K 10-Q · filed 2024-11-13 | -$150.00K derived: sum of 2 quarters · filed 2024-11-13 | -$170.00K 10-Q · filed 2024-11-13 | -$166.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $8.00K 10-Q · filed 2024-08-08 | -$12.00K 10-Q · filed 2024-08-08 | -$8.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$19.00K 10-Q · filed 2024-05-09 | -$16.00K derived: sum of 2 quarters · filed 2024-05-09 | -$7.00K derived: sum of 3 quarters · filed 2024-05-09 | -$7.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $12.00K derived: sum of 2 quarters · filed 2024-02-29 | $12.00K derived: sum of 3 quarters · filed 2024-02-29 | -$35.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $9.00K 10-Q · filed 2023-11-09 | $9.00K derived: sum of 2 quarters · filed 2023-11-09 | -$38.00K 10-Q · filed 2023-11-09 | -$44.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | -$46.00K 10-Q · filed 2023-08-09 | -$53.00K derived: sum of 3 quarters · filed 2023-08-09 | -$66.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$46.00K 10-Q · filed 2023-05-11 | -$53.00K derived: sum of 2 quarters · filed 2023-05-11 | -$66.00K derived: sum of 3 quarters · filed 2023-05-11 | -$66.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$20.00K derived: sum of 2 quarters · filed 2023-03-15 | -$20.00K derived: sum of 3 quarters · filed 2023-03-15 | -$121.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | -$13.00K 10-Q · filed 2022-11-08 | -$13.00K derived: sum of 2 quarters · filed 2022-11-08 | -$114.00K 10-Q · filed 2022-11-08 | -$243.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | -$101.00K 10-Q · filed 2022-08-11 | -$230.00K derived: sum of 3 quarters · filed 2022-08-11 | -$251.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$101.00K 10-Q · filed 2022-05-12 | -$230.00K derived: sum of 2 quarters · filed 2022-05-12 | -$251.00K derived: sum of 3 quarters · filed 2022-05-12 | -$269.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$150.00K derived: sum of 2 quarters · filed 2022-03-28 | -$168.00K derived: sum of 3 quarters · filed 2022-03-28 | -$181.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | -$21.00K 10-Q · filed 2021-11-10 | -$39.00K derived: sum of 2 quarters · filed 2021-11-10 | -$52.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$18.00K 10-Q · filed 2021-08-12 | -$31.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$13.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$46.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Entera Bio Ltd. (ENTX) | $0.485B |